very I'd you everyone, you thank thank Thank questions. Good much. and QX of the you afternoon, XXXX our shareholder for who those like joining have send update call. to
As call. I them try address to during always, this my will best
on continued that hit Pathology exceeding year. we've end track for target that this division. As at grow, reaching pleased to are goals to to inform breakeven so to date, filing saw you our are recent our Revenue the in the QX. for we I'm our the XX-Q track, breakeven QX far, Pathology with of and division in on we last continued week,
We have a solid team.
customer and base is customer new is existing our growing. Our base stable,
reach company this have be our volume HemeScreen gone the customers do, are when their discussed for the remaining we to working its continue the customers live and panels. strategy, three a of the cushion past, progress this ensure towards its excess We quarter, with and will with Pathology entire reach division, Once R&D profitable to In build facility also the Products rapid they three company.
In which breakeven. cost-neutral we the division, breakeven products, within we of are to itself division generating our revenue and In to will is while And an adding to target. as live continue fulfills this purpose large to company's that profitable. serve develop the growing two we division will that make program. to cash go
in to end We can revenue. an which expect the contribute that they're means by expect be into we customers of quarter, going that will these increase in they full-fledged activity, will this QX,
The they third operational live. progress several working and is in through before go customer issues is still
diligently order to ensure fully working onboarded them will third with also are customer We this in too. that be
brings on other course, a Of gone or we our of of with customers formed building have breakeven and the closer we're to midsized orders management that closely the teams it Each the place. We in recipe board. decision customers our and fruits and the see form right progress new the for better to we We've success. the to in. during and have on previous with relationship in distributors call, our company with work the shareholder with to another formulate in yet QX, customer working our of target. hitting the quite to the revamp are the distributors and few either plan block to In these in the us bringing towards and commented the customers targeting, small the to introductions live see work put begun more recurring come QX, distributors starting process makers recipe of revenue I conversations in identify of began those
business. our reason The far, and you we up with distributors effort direct have effort. sales the the are is with distributors time spending scaling so why successful we've been key are to believe that we more of Some the asked when
amount U.S. and focused a worldwide. on the Although total in now, HemeScreen the for market, we're $XXX reaching million annually profitability, just product approximately similar for is the
that of distributors. up the to through our is even at share. way not And X% are We market scale
believe importantly, to building of they They is relationships to distribution hundreds sell best distributors, and are and spent to years far potential market by market know process as like you customers McKesson rapidly build customer But care attempting for with broader takes capture direct. faster and the up partner the Fisher channels, our them.
And who sales that our customers. network what we these Thermo products with tapping way and health opposed business penetration significant to U.S. and the work only Cardinal leveraging employ to establish to customers. those established collectively and to resources base, into and Health, expertise other have with, scale has approach a it relationships. up in within any have Our Therefore, our is decision-makers go and reps that that It's as access channel. the presence time market we field, to share business the enabling distribution most and in more this through the scale no the build efficiently reach secret those successful
to the relationships continue the in foster our program sales. to messaging with We build and work our and refine to distributors help growth to closely
Next, position. I'd our to like discuss cash
you As in of actually $XXX,XXX. in increase approximately an cash we QX, saw had
terrific and are is profitable Change being and confused payers and of the delayed getting from this a to While the close, news, Healthcare fund year, not earlier Change us other billing is returned from yes, payments Medicare hack just this We're yet. including we've aftermath we with issues this Healthcare, be still state yet dealing and collection. not to with steady transfers for
of and we as towards getting to that we better that.
From to target that today, breakeven. cash sufficient we However, reducing returning believe perspective, meet are situation are stand is obligations we operational and towards much reach have profitability we an cash we that to stable year-end. and believe we situation our that the had And prior moving burn moving by our
independent believe two for have company heard stand still reach times, say I You've on point. our resources financially to we many this own and me it's time to feet. that be sufficient our that
believe submit the those have pre-submission accepted been with on process meeting FDA. the like a scheduled soon feel for this this they're application We market in for approval FDA both not we and in the seeing actually the how the a and the sure customers, FDA's ruling to We after from not situation, advantage yet receive that who we're significant for and do. year. decided I'd going to hope us view has our have to been competitive handle believe to We've as manufacturers still what to we Once the product that field credibility and required will read are with ruling for to the us a further around FDA confusion Next, and FDA our submitted we this having received, position of market materials help share We're additional meeting, update FDA few later our of to trial. gain the on competitors. the sometime XXXX. our the to provide provide materials an out will meeting good quite an approval in
on like our performance. price share I'd to Finally, comment
we've suffers at months, seems sorting $X least the to no the from pressures around stable and range, and recent For we hovering it share price longer $X used been experience. the tremendous is that the to
good less a equates translates million, you multiple. Having which that's $X.X to run $XX.X our than this revenues annualized about QX cap a of still take So if of into market that, our rate, million X.Xx thing. revenue said
a company's at observers this the reasonable in doesn't us market to many to seem situation, multiple. and the and comparables at as Looking outside
its two the we keeping ourselves stock current at ask place. We consider factors. price So what's
is and the of we and to performance, is our capital. dilutive still needs skeptical first will market need cash our The believe our revenue still growth raise
hopefully this As quarters of notion entirely. on track, will continue we dissolve the next couple
side and presence company, community. build the and we is the and ours, IR attention with for spent that an battle factor microcap and All to such The and time especially second brand Relations. have personally their the companies investor any companies of Investor significant work investment resources on as not
side. For the we years, time have past on very effort business the expect our building spent little few our and IR
the this times.
In its a and we stabilized presumably revenue with working all through exceeding business a is who the digital side industry focus of audience current share potentially a the to have, price story substantial on company. to that build out will indeed continuous growing X.Xx with our the investor to line a share year should we plan upon comparable. momentum demonstrating of and collection translate of achieve really end investor by to I'm on is more in summary, the business achieving base, number into business place, in presence division impact we results for and the with that multiple key and trading map breakeven and in at of distributors, can at have volume pipeline company's our customer company, new and and good road a Product work to hard backlog is excited the with with an point we're people company scale is that a its business are this combination follow and conferences heading revenue a Pathology in direction. our help and that performance increase of goals and and our a division say, then profitable target the the with that continue market we the that Needless With the coupled its results community.
A meetings, company's of a go with and Our results,
time enough have in We there. gas to get
we're goal can nice to team for will business work Furthermore, our company and you for think work to connecting its rekindling you scaling a as for Product like so pay translate shareholder in your our Thank strategy, week. and I IR you, call. see, hard we as thank as accomplished have our quarterly thinking also all XXXX about on our you that the with well terms I good when forward into look the up off next that of our strategy can value.
I'd the have XXXX. support, reaches
